Outlining the ways FDA is adopting electronic practices and initiating efforts to simplify the submission process for new drug and generic drug applications.
Mary Ann Slack
Advertisement
Mary Ann Slack is Deputy Director, Office of Strategic Programs, Center for Drug Evaluation and Research (CDER), Food & Drug Administration.
Articles by Mary Ann Slack
Advertisement
Latest Updated Articles
Leveraging Health IT to Improve Drug DevelopmentPublished: August 1st 2017 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Bringing Clinical Trials Into the Digital Era with eConsent
2
ACT Brief: AI Innovations, Vision Trial Breakthroughs, and a Major Industry Acquisition
3
Global Breast Cancer Trials Show Progress in Diversity, But Gaps Remain
4
ACT Brief: Digital Consent, Global Diversity, and Clinical Setbacks Shape Today’s Clinical Research Landscape
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
